Scientists develop potential new approach to stop cancer metastasis

Researchers have identified a compound that blocks the spread of pancreatic and other cancers in various animal models. When cancer spreads from one part of the body to another in a process called metastasis, it can eventually grow beyond the reach of effective therapies.

In the four panels on the left, the green dots indicate the presence of PNCs in untreated pancreatic and metastatic liver tumors. On the right, treatment with metarrestin reduced the prevalence of PNCs. Image credit: Frankowski et al., Sci. Transl. Med. 10, eaap8307 (2018)

The team collaborated to identify a compound, which they named metarrestin, that stopped tumor metastasis in multiple animal models. Mice treated with metarrestin also had fewer tumors and lived longer than mice that did not receive treatment.

Many drugs are aimed at stopping cancer growth and killing cancer cells. However, there is no single approved drug specifically aimed at treating metastasis.

In patients, metarrestin potentially could be effective as a therapy after cancer surgery. Because advanced cancers are difficult to completely remove with surgery, doctors typically give chemotherapy to try to kill undetected cancer cells left behind and prevent the cancer from coming back. Metarrestin could be added to such standard drug therapy.

Metarrestin breaks down an incompletely understood component of cancer cells called the perinucleolar compartment (PNC). PNCs are found only in cancer cells, and in a higher number of cells in advanced cancer, when it has spread to other sites in the body.

A team from Northwestern University Feinberg School of Medicine, Chicago, showed early on that the more cancer cells with PNCs in a tumor, the more likely it would spread. Her findings suggested that reducing PNCs might translate to less cancer progression and possibly better outcomes in patients.

To test these ideas, they used National Center for Advancing Translational Sciences (NCATS) expertise in screening, chemistry, compound development and testing to evaluate more than 140,000 compounds for their potential effectiveness in eliminating PNCs in cells in advanced cancer.

While nearly 100 compounds initially showed some activity, the investigators identified one compound that could effectively break down PNCs in advanced prostate cancer cells. With the help of researchers at the University of Kansas, Lawrence, they modified the compound to make it work better as a potential drug and evaluated the effects of the molecule in different assays, or tests, in the laboratory. They found that metarrestin could block the way prostate and pancreatic cancer cells spread.

The group evaluated the effects — including toxicity — of metarrestin in pancreatic cancer mouse models. The investigators found that it prevented the further spread of pancreatic cancer by disrupting the protein-making machinery of cancer cells, and mice treated with metarrestin lived longer than mice without treatment. (National Institutes of Health)

YOU MAY ALSO LIKE

Eating Meat Linked to Higher Risk of Diabetes

Higher intake of red meat and poultry is associated with significantly increased risk of developing diabetes, which is partially attributed to higher content of heme-iron in these meats.

Rheumatoid arthritis mechanisms may vary by joint

An epigenomic analysis of rheumatoid arthritis in knee and hip joints revealed unique patterns that suggest disease mechanisms may differ from joint to joint. The findings could open the door to development of more effective, personalized therapies for rheumatoid arthritis.

Study: Olive Oil Protects Brain From Alzheimer’s

The benefits of a Mediterranean diet are widely chronicled, but new research shows extra-virgin olive oil, a key part of the diet, may protect “against cognitive decline.”

No safe level of smoking: Even low-intensity smokers are at increased risk of earlier death

People who consistently smoked an average of less than one cigarette per day over their lifetime had a 64 percent higher risk of earlier death than never smokers, and those who smoked between one and 10 cigarettes a day had an 87 percent higher risk of earlier death than never smokers, according to a new study from researchers at the National Cancer Institute.

Oxytocin affects facial recognition

A genetic variation in the receptor for oxytocin, a hormone involved in social bonding, affects the ability to remember faces in families with a child who has autism. The finding points the way to a better understanding of oxytocin’s role in social behavior.

Anxiety May Be Alleviated by Changing Gut Bacteria

Anxiety may be alleviated by changing a person’s gut bacteria, new research suggests.